SYN - Synthetic Biologics, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development29,10932,90614,489
Selling General and Administrative10,1438,0746,013
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-39,252-40,980-20,502
Income from Continuing Operations
Total Other Income/Expenses Net11,449-3,805718
Earnings Before Interest and Taxes-27,803-44,785-19,784
Interest Expense---
Income Before Tax-27,803-44,785-19,784
Income Tax Expense---
Minority Interest-1,596-1,048-1,048
Net Income From Continuing Ops-27,255-43,737-19,784
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-27,255-43,737-19,784
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-27,255-43,737-19,784